CIK 0000275053 · Accelerated filer<br>Smaller reporting company
NATURES SUNSHINE PRODUCTS INC
Sign in to watch- Ticker
- NATR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- UT
- Entity type
- operating
- EIN
- 870327982
- Phone
- (801) 341-7900
- Business address
- 2901 WEST BLUEGRASS BLVD., SUITE 100, LEHI, UT, 84048
- Open-market buys, last 90 days
- $3,143,611
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$3,143,611. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-12 | Herbert Kevin R. EVP & President, North America | Sale | −1,134 | $20.63 | $23K | 49,732 |
| 2026-06-12 | Herbert Kevin R. EVP & President, North America | Sale | −866 | $20.75 | $18K | 48,866 |
| 2026-06-05 | Yates Bryant J EVP & President, Europe | Sale | −11,968 | $19.90 | $238K | 77,446 |
| 2026-06-01 | Norman Daniel C EVP & President, Asia | Sale | −9,713 | $20.64 | $200K | 47,276 |
| 2026-05-21 | Brower Nathan G EVP, General Counsel | Sale | −12,015 | $21.84 | $262K | 43,438 |
| 2026-03-13 | Yates Bryant J EVP & President, Europe | Sale | −19,516 | $24.35 | $475K | 85,154 |
| 2026-03-13 | Norman Daniel C EVP & President, Asia | Sale | −15,383 | $24.52 | $377K | 55,693 |
| 2026-03-13 | Lanoy Jonathan David SVP, Chief Accounting Officer | Sale | −4,000 | $24.70 | $99K | 46,405 |
| 2025-12-12 | Yates Bryant J EVP & President, Europe | Sale | −1,700 | $22.29 | $38K | 98,604 |
| 2025-11-18 | Lanoy Jonathan David SVP, Chief Accounting Officer | Sale | −5,000 | $20.45 | $102K | 46,233 |
| 2025-11-14 | Brower Nathan G EVP, General Counsel | Sale | −3,800 | $20.81 | $79K | 46,735 |
| 2025-11-12 | Norman Daniel C EVP & President, Asia | Sale | −8,884 | $20.46 | $182K | 66,636 |
| 2025-08-29 | Yates Bryant J EVP & President, Europe | Sale | −4,672 | $16.71 | $78K | 97,498 |
| 2025-08-26 | Yates Bryant J EVP & President, Europe | Sale | −5,000 | $16.77 | $84K | 102,170 |
| 2025-08-13 | Lanoy Jonathan David SVP, Chief Accounting Officer | Sale | −5,000 | $16.51 | $83K | 50,051 |
| 2025-08-13 | Brower Nathan G EVP, General Counsel | Sale | −9,996 | $16.54 | $165K | 48,277 |
| 2025-06-27 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 10% owner | Sale | −2,854,607 | $11.46 | $32.7M | 0 |
| 2024-10-15 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 10% owner | Sale | −2,300 | $13.02 | $30K | 64,167 |
| 2024-10-14 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 10% owner | Sale | −1,300 | $13.12 | $17K | 66,467 |
| 2024-10-11 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 10% owner | Sale | −1,580 | $13.37 | $21K | 67,767 |
Page 1 of 23 · 450 trades